Helicobacter pylori Infection: Sequential Therapy Followed by Levofloxacin-Containing Triple Therapy provides a Good Cumulative Eradication Rate
Helicobacter, 04/06/2012Manfredi M et al.
Sequential therapy as first–line and levofloxacin–containing triple therapy as second–line represent a good combination to eradicate Helicobacter pylori infection in only two rounds.
The authors treated 231 consecutive Helicobacter pylori-positive patients by sequential therapy and they verified the eradication 8–10 weeks after treatment by stool antigen test.
Patients positive for stool antigen test received levofloxacin-containing triple therapy, as second-line therapy, according to Italian Guidelines and they were again submitted to the fecal test 8–10 weeks after the end of treatment.
In the first-line regimen, they obtained an eradication rate of 92.6%, in the second-line of 75.0% and as cumulative result they achieved a 97.8% of eradication, in per-protocol analysis.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.